Tackling Subretinal Hemorrhage – What Is New?
1 September, 10:30 – 11:30 CEST
Hall 3
Chairperson:
K. Januschowski GERMANY
Diseases of Bruch’s membrane: Monogenic causes, similarities with AMD and therapeutic approaches
1 September, 11:45 – 12:45 CEST
Hall 3
Chairpersons:
K. Pfau SWITZERLAND & C. Cukras USA
Syndromic and Vascular Retinal Disease in Childhood: Diagnosis & Treatment
1 September, 14:45 – 15:45 CEST
Hall 4
Chairpersons:
R. Henderson UK & H. Wuen Chan SINGAPORE
Research Awards Session
2 September, 08:30 – 09:30 CEST
Hall 3
Chairperson:
G. Pertile ITALY & R. Silva PORTUGAL
EVICR.net – European Multinational Clinical Research in Retina
2 September, 08:30 – 09:30 CEST
Hall G2
Chairperson:
J Cunha-Vaz PORTUGAL
Real-World Evidence (RWE) Registries
2 September, 11:00 – 12:00 CEST
Hall 3
Chairperson:
N. Eter GERMANY
How, when and why to use AI in the clinical management of neovascular AMD: A state-of-the-art by the FRB consortium in Europe
2 September, 12:15 – 13:15 CEST
Hall 3
Chairpersons:
U. Schmidt-Erfurth AUSTRIA & C. Creuzot-Garcher FRANCE
RETINATECH: Technology Meets Surgery. A Bio-Engineering Session
2 September, 16:30 – 18:00 CEST
Hall G2
Chairpersons:
T. Rossi ITALY & C. Eckardt GERMANY
Amsterdam Retina Debate
3 September, 12:30 – 13:30 CEST
Hall 3
Chairperson:
S. Lesnik-Oberstein UK
Fighting Post-Operative Endophthalmitis
4 September, 10:15 – 11:15 CEST
Hall 3
Chairperson:
R. Narula INDIA
15 years of anti-VEGF therapy in nAMD – experience, strategies and challenges
4 September, 11:30 – 12:30 CEST
Hall 3
Chairpersons:
D. Pauleikhoff GERMANY & J. Monés SPAIN
New insights in the pathogenesis and progression of age-related chorio-retinal degeneration
4 September, 12:45 – 13:45 CEST
Hall 3
Chairpersons:
G. Querques ITALY & R. Sacconi ITALY
